Similarly, the DNA demethylation in the promoter region of IGF2BP3 could influence the progression of G-CIMP gliomas (67), and cg07166550/ALKBH5 could be used as prognostic biomarkers in prostate cancer (68). Here, ALKBH5 is linked to prostate cancer.